ClinicalTrials.gov
ClinicalTrials.gov Menu

MobileMedMinder: A Networked Aide for Medication Compliances

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01597583
Recruitment Status : Completed
First Posted : May 14, 2012
Last Update Posted : December 10, 2013
Sponsor:
Collaborator:
Limaging
Information provided by (Responsible Party):
Steve Gottlieb, University of Maryland

Brief Summary:
The main aim of this study is to conduct a randomized control trial to compare MobileMedMinder, a mobile phone based medication reminder software product, with currently accepted and empirically supported methods for increasing medication compliance through reminders and tracking.

Condition or disease Intervention/treatment Phase
Heart Failure, Congestive Behavioral: Use of MobileMedMinder Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: MobileMedMinder: A Networked Aide for Medication Compliances
Study Start Date : November 2011
Actual Primary Completion Date : December 2013
Actual Study Completion Date : December 2013

Arm Intervention/treatment
Experimental: Use of MobileMedMinder Behavioral: Use of MobileMedMinder
Use of an intervention to remind patients to take their medications.
No Intervention: Usual care



Primary Outcome Measures :
  1. Compliance [ Time Frame: 3 months ]
    Pill counts will be used to assess compliance



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Taking beta blockers, ACE or ARB, and hydralazine for treatment of HF.

Exclusion Criteria:

  • Inability to understand informed consent
  • Inability to read and understand English

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01597583


Locations
United States, Maryland
University of Maryland
Baltimore, Maryland, United States, 21201
Sponsors and Collaborators
University of Maryland
Limaging

Responsible Party: Steve Gottlieb, Professor, University of Maryland
ClinicalTrials.gov Identifier: NCT01597583     History of Changes
Other Study ID Numbers: HP-00051021
First Posted: May 14, 2012    Key Record Dates
Last Update Posted: December 10, 2013
Last Verified: December 2013

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases